Effects of magnesium, zinc, and chromium supplementation in adults with metabolic syndrome
Not Applicable
Completed
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0001552
- Lead Sponsor
- The Catholic University of Korea, St. Vincent's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Study participants is adults aged 20-70 years who met the revised National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria for metabolic syndrome
Exclusion Criteria
- who took Mg, Zn, Cr supplements in the preceding 3 months,
- who measured elevated liver enzyme levels (ALT > 129 IU/L),
- who measured abnormal renal function(Creatinine > 1.5 mg/dL),
- who had unstable hypertension, arrhythmia or a coronary heart disease event or hospitalization due to coronary heart disease in the preceding 6 months,
- who suffered chronic obstructive pulmonary disease,or neuromuscular diseases,
- who suffered substance abuse, or an unstable psychiatric condition,
- who is pregnancy or in lactation.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method improvement of metabolic syndrome components inbetween supplements group and placebo control group
- Secondary Outcome Measures
Name Time Method association between hair mineral analysis and change of metabolic syndrome components